AccuPulse is developing novel pulsed electric field ablation (PFA) generator and catheters.
AccuPulse is a medical device company developing pulsed field ablation generators and catheters for treating cardiac arrhythmias. Its stated aim is a safer, faster and more affordable treatment for patients.
AccuPulse was founded in 2020 by Jie Yin.
Source: Crunchbase.
AccuPulse may be growing as it is involved in the pulsed field ablation (PFA) market, which is expected to continue growing as the technology matures and gains wider acceptance among electrophysiologists. The repeated mention of AccuPulse in the context of a growing PFA market suggests that the company is actively participating in this expanding sector. The association with a market that is gaining traction indicates that AccuPulse is likely experiencing positive growth in its field.
Source: Crunchbase growth insight.
“At AccuPulse, we are committed to bring revolutionary technology to treat cardiac arrhythmias with safer, faster and affordable solution for patients.” accupulse.com
Source: company website, checked 2026-10-26.
Search verified work emails and direct dials for people at accupulse.com.
Or explore the full B2B database and filter by health care companies.